Join the Chronic Kidney Disease group to help and get support from people like you.
Chronic Kidney Disease News (Page 3)
Related terms: CKD, Chronic Renal Disease, CRD
Multimorbidity Tied to Accelerated Kidney Function Decline in Older Adults
THURSDAY, Dec. 26, 2024 – Multimorbidity is strongly associated with accelerated kidney function decline in older age, according to a study published online Dec. 17 in the Journal of the American...
Multiple Chronic Conditions Can Add Up to Kidney Trouble
THURSDAY, Dec. 19, 2024 – The sicker a senior becomes, the more likely they’re going to develop kidney problems on top of their other health challenges. A new study published Dec. 17 in Journal of t...
Artificially and Sugar-Sweetened Beverages Tied to New Chronic Kidney Disease
THURSDAY, Dec. 19, 2024 – Higher intakes of artificially sweetened beverages (ASBs) and sugar-sweetened beverages (SSBs) are positively associated with developing chronic kidney disease (CKD),...
Arsenic in Drinking Water Tied to Kidney Cancer Risk
THURSDAY, Dec. 19, 2024 – Even low levels of arsenic exposure in drinking water may increase the risk for kidney cancer, according to a study published online Dec. 15 in Environmental Pollution....
Serious Complications Seen With Acetaminophen Use in Seniors
TUESDAY, Dec. 17, 2024 – In older adults, acetaminophen use is associated with serious complications, according to a study published online Nov. 24 in Arthritis Care & Research. Jaspreet Kaur,...
Blood Test Might Help Doctors Spot Multiple Diseases
THURSDAY, Dec. 12, 2024 – A blood draw is a typical part of a person's regular check-up. But that blood sample might hold a lot more useful information about a person’s health than doctors are c...
GLP-1 RAs Reduce Risk for Clinically Important Kidney, CVD Outcomes
FRIDAY, Dec. 6, 2024 – Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce the risk for clinically important kidney and cardiovascular disease outcomes in individuals with type 2 diabetes,...
Study Finds GLP-1 Meds, such as Ozempic, Wegovy, Can Also Help the Kidneys
TUESDAY, Nov. 26, 2024 – The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to...
Bidirectional Association Seen for Sleep Disorders, Chronic Kidney Disease
WEDNESDAY, Nov. 20, 2024 – There are bidirectional associations for sleep disorders with chronic kidney disease (CKD), according to a review published in the November issue of Chronic Kidney...
Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD Stage
TUESDAY, Nov. 19, 2024 – For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with worsening CKD stage, according to a study...
Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier
MONDAY, Nov. 11, 2024 – People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Men with both diabetes and kidney disease will develop heart...
Women, Men on Kidney Dialysis Face Different Heart Risks
FRIDAY, Nov. 8, 2024 – Women have a higher risk of heart failure and stroke than men while undergoing dialysis for kidney failure, a new study shows. However, women also have a lower overall risk of...
American Society of Nephrology, Oct. 23-27
The annual meeting of the American Society of Nephrology (Kidney Week) was held this year from Oct. 23 to 27 in San Diego, attracting attendees from around the world, including nephrology s...
ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in Women
FRIDAY, Nov. 1, 2024 – Chronic kidney disease (CKD) cases and deaths in women surged worldwide between 1990 and 2021, according to a study presented at Kidney Week, the annual meeting of the...
ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
MONDAY, Oct. 28, 2024 – Empagliflozin continues to offer cardiorenal benefits for up to 12 months after discontinuation among patients with chronic kidney disease at risk for progression, according...